[1] |
ZHU Xinzhe, LI Hao, XU Huaxiang, LUO Guopei, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2021
[J]. China Oncology, 2022, 32(1): 1-12.
|
[2] |
CONG Binbin, WANG Yongsheng.
Treatment landscape and challenges of managing the hormone receptor-positive early breast cancer
[J]. China Oncology, 2021, 31(8): 689-696.
|
[3] |
YANG Shipeng , LIU Ying , WANG Xinyue , YANG Yang , QUAN Jishu , LIN Zhenhua .
Clinical significance of PKLR overexpression in the pancreatic cancer
[J]. China Oncology, 2021, 31(8): 704-713.
|
[4] |
GAO Heli, XU Jin, YU Xianjun.
Advances in clinical diagnosis and treatment of gastroenteropancreatic neuroendocrine tumor G3
[J]. China Oncology, 2021, 31(7): 567-573.
|
[5] |
SHEN Yujia , FU Xiaolong .
Research progress of immune contexture in tumorigenesis, progression and prognostic relevance of non-small cell lung cancer
[J]. China Oncology, 2021, 31(11): 1115-1125.
|
[6] |
TANG Rong, SHI Si, ZHANG Bo, XU Jin, WANG Wei, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2020
[J]. China Oncology, 2021, 31(1): 1-10.
|
[7] |
FAN Bo , QI Pan , SU Jianzhi , WEI Shufei , ZHANG Xuan , ZHANG Aili .
Baseline characteristics and survival analysis of patients with prostate cancer in the Fourth Hospital of Hebei Medical University
[J]. China Oncology, 2020, 30(8): 620-625.
|
[8] |
ZHANG Xiaomeng , MA Ningyi , ZHU Hongcheng , AI Dashan , REN Zhigang .
Efficacy and prognostic factors of adjuvant radiotherapy combined with chemotherapy in patients with pancreatic cancer
[J]. China Oncology, 2020, 30(7): 519-524.
|
[9] |
MAO Tiebo, CUI Jiujie, WANG Liwei.
Research progress in pancreatic cancer in 2019 from experimental study to clinical evaluation
[J]. China Oncology, 2020, 30(2): 81-89.
|
[10] |
NING Zhouyu, HUA Yongqiang, XU Litao, ZHUANG Liping, FENG Lanyun, CHEN Hao, WANG Peng, SHEN Yehua, LIN Junhua, CHEN Zhen, MENG Zhiqiang.
Efficacy and safety of nab-paclitaxel plus gemcitabine in the treatment of advanced pancreatic cancer by transcatheter arterial chemotherapy: a retrospective study
[J]. China Oncology, 2020, 30(2): 128-134.
|
[11] |
XU Xinyan , CHEN Jiayan , MAO Jingfang , FAN Min .
Radiotherapy for non-small cell lung cancer: evolution and development
[J]. China Oncology, 2020, 30(10): 777-784.
|
[12] |
LIU Mengqi, JI Shunrong, XU Xiaowu, YU Xianjun.
Advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2019
[J]. China Oncology, 2020, 30(1): 1-10.
|
[13] |
SUN Mingming,BAO Lingjie,YI Xiaofang,XU Congjian,JIANG Wei .
Retrospective analysis of clinical characteristics and prognostic factors in 101 patients with primary fallopian tube carcinoma
[J]. China Oncology, 2019, 29(9): 723-729.
|
[14] |
PAN Zeyan, ZHAN Xianbao.
Current status and future strategies of chimeric antigen receptor T-cells in the treatment of pancreatic cancer
[J]. China Oncology, 2019, 29(7): 481-485.
|
[15] |
ZHU Xuqin,JIA Songlin,QI Jie,SHEN Xuefang,LONG Jiang,MIAO Changhong .
Perioperative factors associated with prognosis of patients after radical resection of pancreatic cancer: a retrospective analysis
[J]. China Oncology, 2019, 29(7): 521-527.
|